Publications by authors named "Mark D Russell"

Claim this Profile
R
Rising rates of sepsis in England: an ecological study.
Victoria B Allen, Katie Bechman, Mark D Russell, Maryam A Adas, Anna L Goodman

Infection· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence and mortality of connective tissue diseases: a population-level cohort study in England from 2012 to 2023.
Samir Patel, Mark D Russell, Katie Bechman, Maryam A Adas, Zijing Yang

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of venous thromboembolism in people with RA: a population-based study in the UK.
Mark D Russell, Katie Bechman, Mark Gibson, Victoria Basey, Michael Mclean

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort study.
Maryam A Adas, Katie Bechman, Mark D Russell, Victoria Allen, Samir Patel

Rheumatology (Oxford)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors: a review of the literature.
Deepak Nagra, Kaiyang Song, Joy Odia, Chris Wincup, Arti Mahto, Mark D Russell

Rheumatology (Oxford)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mandatory specialist approval requirements reduce valproate prescribing: population-based evaluation of a National Patient Safety Alert.
James Galloway, Matthew Jones, Mark Gibson, Kaiyang Song, Katie Bechman, Mark D Russell

BMJ Qual Saf· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in remission rates for rheumatoid arthritis in England and Wales: a population-level cohort study.
Edward Alveyn, Callum Coalwood, Gráinne Farrell, Ella Jackson, Maryam A Adas, Mark D Russell

Rheumatology (Oxford)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and meta-analysis of the efficacy of biologic and targeted synthetic therapies in sarcoidosis.
Katie Bechman, Kathryn Biddle, Aitana Miracle, Kelly He, Mark Gibson, Mark D Russell

Thorax· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Risk of venous thromboembolism in people with rheumatoid arthritis: a population-based study in the UK: reply.
Mark D Russell, Katie Bechman, Mark Gibson, Victoria Basey, Michael Mclean

Rheumatology (Oxford)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.
Andrew D Brown, Louis Fisher, Helen J Curtis, Milan Wiedemann, William J Hulme, Mark D Russell

Br J Clin Pharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept and the risk of malignancy: a meta-analysis across disease indications.
Benjamin P Zuckerman, Mark Gibson, Ritika Roy, Mark Hughes, Daksh Mehta, Mark D Russell

Rheumatology (Oxford)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, prevalence, and mortality of sarcoidosis in England: a population-based study.
Katie Bechman, Mark D Russell, Kathryn Biddle, Mark Gibson, Maryam Adas

Lancet Reg Health Eur· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of comorbidity amongst people with palmoplantar pustulosis: A systematic review and meta-analysis.
David Gleeson, Mark Corbett, Shern P Choy, Treasa Jiang, John Y W Lee, Mark D Russell

J Eur Acad Dermatol Venereol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of septic arthritis in adults with a hot swollen joint: British Society for Rheumatology guideline scope.
Nikita Arumalla, Victoria B Allen, Kavina Shah, Mark D Russell, Zoe Syrimi

Rheumatol Adv Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study.
Deepak Nagra, Katie Bechman, Mark D Russell, Zijing Yang, Maryam A Adas

Rheumatology (Oxford)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study.
Mark D Russell, Zijing Yang, Niamh Dooley, Mark Gibson, Benjamin Zuckerman

Rheumatology (Oxford)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between interleukin-12 p40 subunit and risk of primary Sjögren's disease: a Mendelian randomization study.
Benjamin P Zuckerman, Zijing Yang, Alasdair Warwick, Chris Wincup, Mark D Russell

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply.
Mark D Russell, Mark Gibson, Benjamin Zuckerman, Kanta Kumar, Shirish Dubey

Lancet Rheumatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal trends in hospitalisations for venous thromboembolic events in England: a population-level analysis.
Mark Hughes, Mark D Russell, Ritika Roy, Daksh Mehta, Sam Norton

BMJ Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study.
Mark D Russell, Mark Gibson, Benjamin Zuckerman, Kanta Kumar, Shirish Dubey

Lancet Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driving down the cost of biologics: lessons from a nationalised health-care system.
Mark D Russell, James B Galloway

Lancet· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of visualising healthcare quality performance: a systematic review.
Zijing Yang, Edward Alveyn, Mrinalini Dey, Nikita Arumalla, Mark D Russell

BMJ Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19.
Katie Bechman, Amelia Ca Green, Mark D Russell, Zijing Yang, Bang Zheng

J Infect· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trust performance in managing inflammatory arthritis over time in England and Wales: a latent class analysis approach.
Zijing Yang, Nikita Arumalla, Edward Alveyn, Sarah Gallagher, Elizabeth Price, Mark D Russell

Rheumatol Adv Pract· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of safety warnings on the prescribing of JAK inhibitors.
Mark D Russell, Zijing Yang, Ben Walter, Edward Alveyn, Katie Bechman

Lancet Rheumatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis